Lynx1 Capital Management LP

10% Owner
Lynx1 Capital Management LP
$104,905,000.00
%
COMPANY
SHARES
NET TOTAL
24.94%
BELLUS HEALTH INC NEW
2,831,588
$26,164,000.00
21.61%
MERUS N V
1,001,217
$22,668,000.00
20.13%
KINNATE BIOPHARMA INC
1,674,677
$21,118,000.00
15.63%
ALPINE IMMUNE SCIENCES INC
1,926,869
$16,398,000.00
7.28%
CYMABAY THERAPEUTICS INC
2,589,679
$7,640,000.00
5.75%
PIERIS PHARMACEUTICALS INC
3,223,334
$6,028,000.00
3.65%
IMMUNIC INC
1,104,241
$3,832,000.00
0.95%
PASSAGE BIO INC
421,410
$995,000.00
0.06%
OTONOMY INC
30,000
$62,000.00